Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Online Letters: Observations

Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years

  1. Michael Tansey, MD1,
  2. Stuart Weinzimer, MD2,
  3. Roy Beck, MD, PHD3,
  4. Katrina Ruedy, MSPH3,
  5. Peiyao Cheng, MPH3,
  6. William Tamborlane, MD2,
  7. Craig Kollman, PHD3,
  8. Nelly Mauras, MD4,
  9. Larry Fox, MD4,
  10. Julie Coffey, ARNP1,
  11. Neil H. White, MD5,
  12. for the Diabetes Research in Children Network (DirecNet) Study Group
  1. 1Division of Pediatric Endocrinology, University of Iowa, Iowa City, Iowa
  2. 2Section of Pediatric Endocrinology, Yale University, New Haven, Connecticut
  3. 3Jaeb Center for Health Research, Tampa, Florida
  4. 4Pediatric Endocrinology, Nemours Children’s Clinic, Jacksonville, Florida
  5. 5Department of Pediatrics, Washington University, St. Louis, Missouri.
  1. Corresponding author: Katrina Ruedy, direcnet{at}jaeb.org.
Diabetes Care 2013 May; 36(5): e63-e63. https://doi.org/10.2337/dc12-2021
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

In a 6-month randomized trial of continuous glucose monitoring (CGM) in children 4–9 years of age with type 1 diabetes (1), the DirecNet Study Group reported no difference in change in A1C between the CGM and usual care groups, although parents expressed high satisfaction with use of CGM. In a 6-month posttrial phase, the CGM group continued to use CGM and the control group was started on CGM. This observation provides a summary of the findings for both groups during this posttrial phase.

Sixty-four of the 69 children in the CGM group who completed the trial participated in the extension phase; all 64 completed the 12-month visit. Baseline A1C was 7.9 ± 0.8 and 7.8 ± 0.8% at the beginning of the extension phase and 7.9 ± 0.8% at 12 months. During the extension phase, A1C decreased ≥0.5% in 14% and increased ≥0.5% in 25%. Sensor use dropped from a median of 92 h/week at 6 months to 60 h/week at 12 months; 33% of subjects were wearing the sensor ≥6 days/week at 12 months, compared with 44% at 6 months. There was no correlation between sensor use and change in A1C during the extension phase and no significant differences in glycemic profiles between the initial 6 month and extension phases. Severe hypoglycemia rate dropped from 9.5 events/100 person-years in the first 6 months to 3.3 in the extension phase, with no seizures or loss of consciousness. On the CGM Satisfaction questionnaire, parents continued to endorse feeling safer with use of CGM and that CGM made adjusting insulin easier.

Of the 68 children in the control arm who completed the initial 6-month trial, 66 initiated CGM in the posttrial phase; 61 completed the 12-month visit. Mean A1C was 7.8 ± 0.8% at CGM initiation and 7.8 ± 0.7% 6 months later (P = 0.54). A decrease in A1C ≥0.5% was seen in 21% and an increase in A1C ≥0.5% was seen in 31%. CGM wear decreased from a median of 95 h/week during the first month to 32 h/week at the end of the study. Only 16% of subjects were using CGM ≥6 days/week by study end. Significant improvements from 6 to 12 months were observed for the percentage of sensor values ≤70 mg/dL (median 2.2 vs. 1.4%; P = 0.001) and the coefficient of variation (41 vs. 37%; P < 0.001), but the percentage in the target range 71–180 mg/dL was similar (52 vs. 54%). Severe hypoglycemia rate was 13.3/100 person-years (four events in 61 participants). The CGM Satisfaction questionnaire completed by parents indicated high benefit and low hassles with CGM despite the lack of improvement in glycemic indices.

Despite parental reports of great satisfaction with CGM, glycemic control did not improve in these young children, and sensor use progressively decreased. Identifying barriers to improved glycemic control will be important in future studies of young children with type 1 diabetes who use CGM. Meaningful improvement in control and reduction in hypoglycemia in this group may require closed-loop insulin delivery.

Acknowledgments

This research was supported by the following National Institutes of Health (NIH)/National Institute of Child Health and Human Development grants: HD41890-10, HD41906-10, HD41908-10, HD41915, HD41918, and HD56526. This publication was also made possible by grants UL1 RR024992, UL1RR024979, UL1RR024139, and UL1RR025744 from the National Center for Research Resources, a component of NIH, and the NIH Roadmap for Medical Research.

M.T. consults for Daiichi Sankyo. S.W. consults for Animas and BD, has received a grant from Medtronic for in-kind support, has received payment for lectures and service on speaker bureaus for Eli Lilly, and has received payment for InsuLine stock. W.T. consults for Medtronic and LifeScan Animas. C.K. has consulted with Diabetes Technology Management. N.M. reports a device supply agreement with Medtronic for a research project. N.H.W. received institutional funds to support travel and for other purposes from NIH/National Institute of Child Health and Human Development, and consults for Novo Nordisk and Daiichi Sankyo.

M.T., S.W., R.B., and K.R. researched data, contributed to discussion, wrote the manuscript, and reviewed and edited the manuscript. P.C., W.T., C.K., N.M., L.F., J.C., and N.H.W. researched data, contributed to discussion, and reviewed and edited the manuscript. R.B. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Footnotes

  • The opinions expressed in this article are those of the authors and do not necessarily reflect the views of the National Institutes of Health or the National Center for Research Resources.

  • © 2013 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

References

  1. ↵
    1. Mauras N,
    2. Beck R,
    3. Xing D,
    4. et al
    .; Diabetes Research in Children Network (DirecNet) Study Group. A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years. Diabetes Care 2012;35:204–210
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Diabetes Care: 36 (5)

In this Issue

May 2013, 36(5)
  • Table of Contents
  • About the Cover
  • Index by Author
  • Podcast
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years
Michael Tansey, Stuart Weinzimer, Roy Beck, Katrina Ruedy, Peiyao Cheng, William Tamborlane, Craig Kollman, Nelly Mauras, Larry Fox, Julie Coffey, Neil H. White, for the Diabetes Research in Children Network (DirecNet) Study Group
Diabetes Care May 2013, 36 (5) e63; DOI: 10.2337/dc12-2021

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Extended 6-Month Follow-Up of A Randomized Clinical Trial to Assess the Efficacy and Safety of Real-Time Continuous Glucose Monitoring in the Management of Type 1 Diabetes in Young Children Aged 4 to <10 Years
Michael Tansey, Stuart Weinzimer, Roy Beck, Katrina Ruedy, Peiyao Cheng, William Tamborlane, Craig Kollman, Nelly Mauras, Larry Fox, Julie Coffey, Neil H. White, for the Diabetes Research in Children Network (DirecNet) Study Group
Diabetes Care May 2013, 36 (5) e63; DOI: 10.2337/dc12-2021
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Acknowledgments
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Effect of the Holiday Season in Patients With Diabetes: Glycemia and Lipids Increase Postholiday, but the Effect Is Small and Transient
  • Artifactual Hypoglycemia: An Old Term for a New Classification
  • Tyrosine Kinase Inhibitor Sunitinib Allows Insulin Independence in Long-standing Type 1 Diabetes
Show more Online Letters: Observations

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.